Sunshine Guojian Pharmaceutical (688336.SH) has announced a forecasted net profit of 700 million to 772 million yuan, an increase of 137.73% to 162% compared to the previous year.
San Sheng Guojian (688336.SH) released the annual performance forecast for 2024, with the company expected to achieve...
Sunshine Guojian Pharmaceutical (688336.SH) released its annual performance forecast for 2024, with an estimated net profit attributable to the company's owners of 7 billion to 7.72 billion yuan, an increase of 137.73% to 162.00% year-on-year; it is expected to achieve a net profit attributable to the company's owners after deducting non-recurring gains and losses of 2.39 billion to 2.79 billion yuan, an increase of 15.57% to 34.83% year-on-year.
Related Articles
US Stock Market Move | Gold and silver mining stocks generally fell, with Hecla Mining Company (HL.US) dropping 3.5%.
US Stock Market Move | YARTEMLEA drug receives FDA approval Omeros Corporation (OMER.US) surges by nearly 65%
US Stock Market Move | The US car safety regulatory agency has launched a defect investigation into the Model 3. Tesla, Inc. (TSLA.US) fell more than 1.4% in the short term.
US Stock Market Move | Gold and silver mining stocks generally fell, with Hecla Mining Company (HL.US) dropping 3.5%.
US Stock Market Move | YARTEMLEA drug receives FDA approval Omeros Corporation (OMER.US) surges by nearly 65%
US Stock Market Move | The US car safety regulatory agency has launched a defect investigation into the Model 3. Tesla, Inc. (TSLA.US) fell more than 1.4% in the short term.
RECOMMEND
